Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC is intensifying enforcement against substandard, falsified, and counterfeit health products through blacklisting, watchlisting, and public alerts, while also mandating updated clinical trial regulation training. For Nigerian SMBs in pharmaceuticals, healthcare, and consumer goods, this means stricter supply chain scrutiny and a need to verify product authenticity and supplier compliance. Additionally, a guide on NEPC fish farm registration signals ongoing support for export-oriented agribusinesses.
Pharmaceuticals and healthcare
Importation and distribution
Retail and consumer goods
Agribusiness and export
NAFDAC and NHREC Announce New Dates for Mandatory Stakeholders Training on Clinical Trial Regulations in Nigeria
NAFDAC
NAFDAC and NHREC have rescheduled mandatory stakeholder training on clinical trial regulations, with new dates announced.
SMBs involved in clinical trials or pharmaceutical research must ensure their staff attend the training to remain compliant with regulatory requirements.
Public Notice on Blacklisting Ayrtons Saunders Ltd, UK
NAFDAC
NAFDAC has blacklisted Ayrtons Saunders Ltd, UK, and its products, warning the public and healthcare stakeholders.
SMBs importing or distributing products from this company must immediately cease and verify their supply chains to avoid regulatory penalties.
Public Alert No. 043/2026 - NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist
NAFDAC
NAFDAC has placed products marketed by Mofus Nigeria Ltd on a watchlist pending regulatory investigation.
Retailers, distributors, and PPMVs should quarantine these products and await further directives to avoid legal repercussions.
Public Alert No. 042/2026 - Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC seized a suspected substandard and falsified antimalarial medicine, BPPL Artemether/Lumefantrine 80mg/480mg.
Pharmacies and healthcare providers must check their stock for this product and report any findings to NAFDAC to protect patients and avoid liability.
Public Alert No. 041/2026 - Alert on Suspected Counterfeit ORACIRE+ Toothpaste
NAFDAC
NAFDAC warns of counterfeit ORACIRE+ toothpaste being sold as the registered ORACARE+ toothpaste.
Retailers and distributors of oral care products should verify product authenticity and source only from approved suppliers to avoid selling counterfeits.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide
Other
A guide on registering fish farms with the Nigerian Export Promotion Council (NEPC) for export purposes.
SMBs in aquaculture can leverage this guide to formalize their operations and access export opportunities, potentially increasing revenue.
Increased regulatory scrutiny on pharmaceutical and healthcare product supply chains.
Rising risk of counterfeit and substandard products entering the market.
Mandatory training requirements for clinical trial stakeholders.
Export opportunities for registered agribusinesses, particularly fish farming.
1
Verify all pharmaceutical and healthcare products against NAFDAC alerts and blacklists before importation or distribution.
2
Attend NAFDAC/NHREC mandatory training on clinical trial regulations if involved in clinical trials.
3
Quarantine and report any products mentioned in NAFDAC alerts to the agency.
4
Register fish farms with NEPC to access export markets and comply with export regulations.
5
Conduct regular supply chain audits to ensure product authenticity and regulatory compliance.